Carmell Therapeutics Corp... (CTCX)
0.49
16.11%
At close: Jan 10, 2025, 3:56 PM
0.44
-10.43%
After-hours Jan 10, 2025, 07:59 PM EST
undefined% (undefined)
| Bid | 0.43 |
| Market Cap | 10.27M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 1.02 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.45 |
| Volume | 3,758,266 |
| Avg. Volume (20D) | 10,925,326 |
| Open | 0.42 |
| Previous Close | 0.42 |
| Day's Range | 0.42 - 0.65 |
| 52-Week Range | 0.20 - 4.00 |
| Beta | undefined |
About CTCX
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was foun...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 23, 2021
Employees 9
Stock Exchange NASDAQ
Ticker Symbol CTCX
Website https://www.carmellrx.com
1 week ago ·
Source
+147.98%
Carmell Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 weeks ago ·
Source
+26.2%
Carmell shares are trading higher after the announced it has entered securities purchase agreement with new and existing investors.
